Meet with...NCI | Application Deadline August 6, 2010

Application Deadline August 6, 2010

The National Cancer Institute (NCI) recently introduced the Small Business Innovation Research (SBIR) Phase II Bridge Award mechanism, designed to incentivize their phase II awardees to obtain 3rd party financing in order commercialize technologies developed with SBIR funds.

In this session, Directors from the NCI SBIR Development Center will talk to current and potential grantees about the Bridge Award and other opportunities such as their contract topics.

After the presentation, each attendee will have a private meeting with Mr. Michael Weingarten - the Director of the NCI SBIR Development Center - and/or Dr. Ali Andalibi - the Program Director of the NCI SBIR Development Center.

To apply for one-on-one meetings, please send your Executive Summary by August 6, 2010 to [email protected]. The Review Board, composed of the BioCenter management team, sponsors, partners and mentors, will then meet to consider your application.

One-on-one Meetings
The one-on-one meetings will take place on August 24th at Townsend & Twonsend, Palo Alto, CA.

Funds Available
The NCI intends to commit $10,000,000 in fiscal year 2009 to fund five to ten applications submitted in response to this FOA. For this funding opportunity, budgets up to $1,000,000 in total costs (direct and F&A costs plus fee) per year and project periods up to 3 years may be requested from the NCI. Awards issued under this FOA are contingent upon the availability of funds and the submission of a sufficient number of meritorious applications. The total amount awarded and the number of awards will depend upon the quality, duration, and costs of the applications received. Future year amounts will depend on annual appropriations.

Speakers
* Michael Weingarten, Director, NCI SBIR Development Center, National Cancer Institute
* Ali Andalibi, Ph.D., Program Director, NCI SBIR Development Center, National Cancer Instite

Official Website: http://www.sjbiocenter.com/event/ev_2010Q3-MeetWithNCI.html